Target intelligence / Profile preview

Extracellular matrix–cell surface receptors and tissue components (ECM-cell surface receptors)

Target
ECM-cell surface receptors
Molecular classification
Other
01

Overview

Extracellular matrix–cell surface receptors and tissue components refers to a broad biological category encompassing the interactions between the extracellular matrix (ECM) and various cell-surface proteins, as defined in the Reactome pathway database (R-HSA-446728). This group includes major receptor families such as integrins, syndecans, and discoidin domain receptors, as well as ECM structural proteins like collagens, laminins, and fibronectin (Source: UniProt). These interactions are fundamental to cell adhesion, migration, and the transmission of biochemical and mechanical signals that regulate cell survival and differentiation (Source: StatPearls, PMID: 30020607). In pathological states, dysregulation of these components contributes significantly to cancer metastasis, tissue fibrosis, and chronic inflammatory diseases (Source: Nature Reviews Cancer, PMID: 24903765). While the category itself is not a single drug target, many of its individual members, particularly integrins, are critical therapeutic targets for treating cardiovascular, autoimmune, and oncological conditions (Source: PubMed, PMID: 28839151).

Other names
Cell-extracellular matrix interactionsECM-receptor interactionExtracellular matrix organizationCell-matrix adhesion
02

Mechanism of action

Antagonism of cell-surface receptors (primarily integrins) to inhibit binding to extracellular matrix ligands, thereby modulating cell adhesion and downstream signaling pathways.

03

Biological functions

Cell adhesionSignal transductionExtracellular matrix organizationCell migrationTissue homeostasis
04

Disease associations

CancerFibrosisCardiovascular diseaseInflammationAutoimmune disease
05

Safety considerations

Increased risk of infectionBleeding diathesisImpaired wound healingProgressive multifocal leukoencephalopathy (PML)
06

Interacting drugs

Abciximab

5 more in the full profile.

07

Biomarkers

Integrin beta-3 expressionCollagen type I C-telopeptide (CTX-I)Soluble VCAM-1Fibronectin levels

Beyond the preview

Go deeper on Extracellular matrix–cell surface receptors and tissue components (ECM-cell surface receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix–cell surface receptors and tissue components (ECM-cell surface receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call